UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis

Science signaling, 2009-06, Vol.2 (77), p.ra31

2009

Volltextzugriff (PDF)

Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3

Molecular cancer therapeutics, 2012-03, Vol.11 (3), p.582-593

2012

Volltextzugriff (PDF)

Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients

The American journal of pathology, 2013-11, Vol.183 (5), p.1446-1460

2013

Volltextzugriff (PDF)

Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD

Molecular and Cellular Biology, 1997-08, Vol.17 (8), p.4750-4760

1997

Volltextzugriff (PDF)

Differentially Expressed Fibroblast Growth Factors Regulate Skeletal Muscle Development through Autocrine and Paracrine Mechanisms

The Journal of cell biology, 1996-03, Vol.132 (6), p.1151-1159

1996

Volltextzugriff (PDF)

The FGF Receptor-1 Tyrosine Kinase Domain Regulates Myogenesis but Is Not Sufficient to Stimulate Proliferation

The Journal of cell biology, 1998-07, Vol.142 (1), p.241-250

1998

Volltextzugriff (PDF)

Potential regulators of HER2 activity in HER2-overexpressing gastric and gastroesophageal tumors: Analysis of HER3 and heregulin expression

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.48-48

2014

Volltextzugriff (PDF)

Preclinical activity of MM-111, a bispecific ErbB2/ErbB3 antibody in previously treated ErbB2-positive gastric and gastroesophageal junction cancer

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.48-48

2013

Volltextzugriff (PDF)

Abstract 1888: MM-111, a bispecific HER2 and HER3 antibody, inhibits trastuzumab-resistant tumor cell growth

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1888-1888

2012

Volltextzugriff (PDF)

Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally advanced therapy

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS4148-TPS4148

2014

Volltextzugriff (PDF)

Role of FGFs in skeletal muscle and limb development

Molecular reproduction and development, 1994-09, Vol.39 (1), p.90-101

1994

Volltextzugriff (PDF)

Abstract 655: Combination of MM-111, an ErbB2/ErbB3 bispecific antibody, with endocrine therapies as an effective strategy for treatment of ER+/HER2+ breast cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.655-655

2011

Volltextzugriff (PDF)

Abstract 654: MM-111, an ErbB2/ErbB3 bispecific antibody, effectively combines with lapatinib to inhibit growth of ErbB2-overexpressing tumor cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.654-654

2011

Volltextzugriff (PDF)

Conservation of Ligand Specificity between the Mammalian and Amphibian Fibroblast Growth Factor Receptors

The Journal of biological chemistry, 1995-12, Vol.270 (48), p.29018-29024

1995

Volltextzugriff (PDF)

Abstract 3485: MM-111, an ErbB2/ErbB3 bispecific antibody with potent activity in ErbB2-overexpressing cells, positively combines with trastuzumab to inhibit growth of breast cancer cells driven by the ErbB2/ErbB3 oncogenic unit

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3485-3485

2010

Volltextzugriff (PDF)

Differential effects of Ras signaling through NFκB on skeletal myogenesis

Oncogene, 2001-03, Vol.20 (11), p.1276-1286

2001

Volltextzugriff (PDF)

Differential effects of Ras signaling through NF[kappa]B on skeletal myogenesis

Oncogene, 2001-03, Vol.20 (11), p.1276

2001

Volltextzugriff (PDF)

A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways

Molecular and Cellular Biology, 1995-06, Vol.15 (6), p.3238-3246

1995

Volltextzugriff (PDF)

Are fibroblast growth factors regulators of myogenesis in vivo?

Progress in growth factor research, 1994, Vol.5 (2), p.145-158

1994

Volltextzugriff (PDF)

Hydra Reaggregation: A Rapid Assay to Predict Teratogenic Hazards Induced by Environmental Toxicity

Journal of the Washington Academy of Sciences, 1984-12, Vol.74 (4), p.102-107

Kudla, Arthur J.

1984

Volltextzugriff (PDF)

Role of FGFs in skeletal muscle and limb development. Questions and answers

Molecular reproduction and development (Print), 1994, Vol.39 (1), p.90-101

1994

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)
Tagungsberichte
(1)

Sprache

Englisch
(21)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Animals
(10)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Mice
(8)
Cell Biology
(7)
Biochemistry & Molecular Biology
(6)
Cell Differentiation
(5)
Humans
(5)
Myogenesis
(4)
Protein Binding
(4)
Receptors, Fibroblast Growth Factor - Physiology
(4)
Signal Transduction
(4)
Skeletal Muscle
(4)
Cell Division
(3)
Cell Growth
(3)
Cell Line
(3)
Fibroblast Growth Factors
(3)
Fibroblast Growth Factors - Physiology
(3)
Muscle, Skeletal - Cytology
(3)
Receptors
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis

Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3

Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients

Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD

Differentially Expressed Fibroblast Growth Factors Regulate Skeletal Muscle Development through Autocrine and Paracrine Mechanisms

The FGF Receptor-1 Tyrosine Kinase Domain Regulates Myogenesis but Is Not Sufficient to Stimulate Proliferation

Potential regulators of HER2 activity in HER2-overexpressing gastric and gastroesophageal tumors: Analysis of HER3 and heregulin expression

Preclinical activity of MM-111, a bispecific ErbB2/ErbB3 antibody in previously treated ErbB2-positive gastric and gastroesophageal junction cancer

Abstract 1888: MM-111, a bispecific HER2 and HER3 antibody, inhibits trastuzumab-resistant tumor cell growth

Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally advanced therapy

Role of FGFs in skeletal muscle and limb development

Abstract 655: Combination of MM-111, an ErbB2/ErbB3 bispecific antibody, with endocrine therapies as an effective strategy for treatment of ER+/HER2+ breast cancer

Abstract 654: MM-111, an ErbB2/ErbB3 bispecific antibody, effectively combines with lapatinib to inhibit growth of ErbB2-overexpressing tumor cells

Conservation of Ligand Specificity between the Mammalian and Amphibian Fibroblast Growth Factor Receptors

Abstract 3485: MM-111, an ErbB2/ErbB3 bispecific antibody with potent activity in ErbB2-overexpressing cells, positively combines with trastuzumab to inhibit growth of breast cancer cells driven by the ErbB2/ErbB3 oncogenic unit

Differential effects of Ras signaling through NFκB on skeletal myogenesis

Differential effects of Ras signaling through NF[kappa]B on skeletal myogenesis

A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways

Are fibroblast growth factors regulators of myogenesis in vivo?

Hydra Reaggregation: A Rapid Assay to Predict Teratogenic Hazards Induced by Environmental Toxicity

Role of FGFs in skeletal muscle and limb development. Questions and answers

Suchergebnisse filtern